VIKING THERAPEUTICS INC's ticker is VKTX and the CUSIP is 92686J106. A total of 143 filers reported holding VIKING THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.72 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $993 | +1.4% | 89,741 | +48.5% | 0.08% | -13.3% |
| Q2 2023 | $979 | -49.3% | 60,422 | -47.9% | 0.10% | -48.7% |
| Q1 2023 | $1,932 | -4.7% | 116,040 | -46.2% | 0.19% | -24.2% |
| Q4 2022 | $2,027 | -99.7% | 215,651 | -2.6% | 0.25% | +215.0% |
| Q3 2022 | $602,000 | +24.4% | 221,483 | +32.3% | 0.08% | +9.6% |
| Q2 2022 | $484,000 | +15.5% | 167,356 | +19.8% | 0.07% | +30.4% |
| Q1 2022 | $419,000 | +18.7% | 139,664 | +82.1% | 0.06% | +27.3% |
| Q4 2021 | $353,000 | +5.1% | 76,700 | +43.2% | 0.04% | +29.4% |
| Q3 2021 | $336,000 | +65.5% | 53,578 | +57.8% | 0.03% | +47.8% |
| Q2 2021 | $203,000 | -46.2% | 33,960 | -43.1% | 0.02% | -63.5% |
| Q1 2021 | $377,000 | -8.5% | 59,641 | -18.4% | 0.06% | -6.0% |
| Q4 2020 | $412,000 | +554.0% | 73,099 | +570.6% | 0.07% | +509.1% |
| Q3 2020 | $63,000 | -38.8% | 10,901 | -19.3% | 0.01% | -8.3% |
| Q4 2018 | $103,000 | -72.0% | 13,507 | -36.0% | 0.01% | -40.0% |
| Q3 2018 | $368,000 | -31.1% | 21,100 | -62.5% | 0.02% | -23.1% |
| Q2 2018 | $534,000 | – | 56,300 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| APIS CAPITAL ADVISORS, LLC | 148,000 | $1,638,360 | 2.12% |
| Sio Capital Management, LLC | 595,002 | $6,586,672 | 2.04% |
| 5AM Venture Management, LLC | 585,000 | $6,475,950 | 1.86% |
| Artia Global Partners LP | 383,580 | $4,246,231 | 1.76% |
| Integral Health Asset Management, LLC | 800,000 | $8,856,000 | 1.23% |
| Boxer Capital, LLC | 2,000,000 | $22,140,000 | 1.18% |
| DAFNA Capital Management LLC | 319,655 | $3,538,581 | 1.10% |
| Affinity Asset Advisors, LLC | 332,600 | $3,681,882 | 1.04% |
| MPM BioImpact LLC | 325,000 | $3,597,750 | 0.96% |
| Affinity Asset Advisors, LLC | 300,000 | $3,321,000 | 0.93% |